Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: J Biomed Inform. 2019 Jun 27;96:103246. doi: 10.1016/j.jbi.2019.103246

Table 5.

Patient similarity measurement between HPOEmb-Orphanet and five conventional similarity measurements (The highest similarity score in bold.)

Rare diseases Shared same phenotypes per pairwise patients (average percentage) HPOSim-Lin HPOSim-ICE HPOSim-RL HPOSim-GIC HPOSim-Wang HPOEmb-Orphanet
ovarian cancer 6.67% 0.42 0.31 0.38 0 0.41 0.55
myelofibrosis 2.5% 0.25 0.17 0.28 0.11 0.23 0.33
primary sclerosing cholangitis 10% 0.42 0.29 0.36 0.05 0.46 0.56
b-cell lymphoma 50% 1 0.83 0.99 1 1 1
dilated cardiomyopathy 43.2% 0.97 0.72 0.91 0 0.96 0.95
laryngomalacia 43.3% 1 0.82 0.99 1 1 0.9
cryoglobulinemia 9.64% 0.09 0.06 0.08 0.04 0.4 0.56
esophageal cancer 5% 0.23 0.17 0.22 0 0.25 0.36
papillary thyroid carcinoma 43.3% 1 0.84 0.99 1 1 0.97
clear cell renal cell carcinoma 46% 1 0.82 0.99 1 1 0.96
Average 26% 0.64 0.5 0.62 0.42 0.67 0.71